PTCH1 and embryonal rhabdomyosarcoma: In addition to syndromic diseases, PTCH1 mutations have been implicated in several cancers including sporadic basal cell carcinoma (BCC) [29], squamous cell carcinoma [30], medulloblastoma [8], and embryonal rhabdomyosarcoma [31].